ALIVUS LIFE SCIENCES LIMITED — Call Transcript 2025

Nov 7, 2025

==> picture [596 x 123] intentionally omitted <==

November 07, 2025

To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS

Dear Sirs,

Sub: Audio recording of Q2 FY2026 Earnings Call

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2026 Earnings Call held on November 07, 2025 on the website of the Company at:

• • • • https://bunny wp pullzone zhbiessutg.b cdn.net/alivus_pdfs/investors/financials/reports_presentation/10037134.mp3

Request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Alivus Life Sciences Limited

(formerly Glenmark Life Sciences Limited)

RUDALF Digitally signed by RUDALF JOSEPH JOSEPH CORRIEA Date: 2025.11.07 CORRIEA 14:56:08 +05'30' Rudalf Corriea Company Secretary & Compliance Officer

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited)

Corporate Office: Registered Office: Technopolis Knowledge Park, A wing, Office No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate 4th Floor, Mahakali Caves Road, Andheri (E), Mumbai – 400093 Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com

Registered Office: Plot No 170-172, Chandramouli Industrial Estate Mohol Bazarpeth, Solapur 413 213, India